The Patent Finder

Terms ending in 2028

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,198,448Fused Heterocyclic Derivatives and Methods of Use
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 9,981,988Polymorphic Forms and Co-Crystals of a C-Met Inhibitor
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 10,328,062Biomarkers and Use of Met Inhibitor for Treatment of Cancer
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 7,759,344Bis-Aryl Amide Derivatives and Methods of Use
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 9,283,260Lyophilized therapeutic peptibody Formulations
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 7,427,638(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 7,816,367Compounds, Pharmaceutical Compositions and Methods for Use in Treating Metabolic Disorders
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 7,834,162Methods and Systems for Isolating Target Molecules from Complex Solutions by Column-Chromatography Using Eluants Containing Organic Solvents
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 7,585,500Fully Human Monoclonal Antibodies to IL-13
In force
 · High confidence
Amgen Fremont Inc.In forceHigh confidence
US 8,021,333Syringe Spring Retainer
In force
 · High confidence
Amgen Inc.In forceHigh confidence
64 more term ends in 2028 · Pro
10 of 74 patents shown. Soonest term end first, then patent number.
Pro members see all 74, including 23 expiring within the 18 months from Nov 20, 2026.
Upgrade to Pro
72 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited